Ravulizumab (Ultomiris) is a powerful medicine given as an intravenous infusion in a hospital setting to treat certain serious neuro-ophthalmological conditions like NMOSD and refractory MG.
| Drug class | Complement Inhibitor |
|---|---|
| Type | Single |
| Forms | IV Infusion |
| Common strength | Per protocol |
| Common Indian brands | Ultomiris |
| Prescription status | Prescription (hospital use) |
What Ravulizumab is used for
Ravulizumab is a specialized medicine primarily used to treat certain serious conditions that affect the nervous system and can have a significant impact on your eyes and overall health. These conditions are:
- Neuromyelitis Optica Spectrum Disorder (NMOSD): This is a rare, long-term autoimmune disorder that mainly affects the optic nerves (which send signals from your eyes to your brain) and the spinal cord. In NMOSD, the body’s immune system mistakenly attacks its own healthy cells, leading to inflammation and damage. This can cause symptoms such as vision loss, pain in the eyes, weakness or numbness in the limbs, and problems with balance and bladder control. Ravulizumab helps to reduce the frequency and severity of attacks in patients with NMOSD.
- Refractory Myasthenia Gravis (MG): Myasthenia Gravis is a chronic autoimmune disorder that causes weakness in the voluntary muscles, meaning muscles you can control. In refractory MG, the condition is severe and does not respond well to standard treatments. This muscle weakness can affect various parts of the body, including the eye muscles (leading to drooping eyelids or double vision), facial muscles, and muscles involved in swallowing and breathing. Ravulizumab is used when other treatments have not been effective in managing the severe symptoms of Myasthenia Gravis.
It is important to understand that these are complex conditions, and Ravulizumab is used as part of a comprehensive treatment plan under the guidance of specialists.
How it works
Ravulizumab works by targeting and blocking a specific part of the immune system called the C5 complement protein. The complement system is a part of your body’s natural defense mechanism, but in conditions like NMOSD and refractory MG, it can become overactive and mistakenly attack healthy tissues, leading to inflammation and damage. By blocking the C5 complement protein, Ravulizumab helps to reduce this harmful activity, thereby preventing or reducing the severity of attacks and symptoms associated with these conditions. It is considered a long-acting blocker, which allows for less frequent dosing compared to some other treatments.
How it’s used
Ravulizumab is administered as an intravenous (IV) infusion, which means the medicine is slowly given directly into your vein through a drip. This procedure is always performed by healthcare professionals in a hospital or clinic setting. It is never for self-use at home.
The typical dosing schedule for Ravulizumab is an IV infusion every 8 weeks. Your doctor will determine the exact strength and duration of each infusion based on your specific condition, body weight, and how you respond to the treatment. It is crucial to attend all your scheduled appointments for these infusions to ensure the medicine works effectively and to maintain its benefits.
During the infusion, you will be monitored closely by the medical staff to ensure your safety and to manage any potential reactions. After the infusion, you can usually go home, but your doctor will provide specific instructions regarding any post-infusion care or observations.
Always follow your ophthalmologist’s exact instructions.
Brands available in India
- Ultomiris
Brand availability and pricing vary; confirm with your pharmacist.
Please note
Powerful medicine that suppresses the immune system. Screening for tuberculosis and hepatitis is usually required before starting, and it raises the risk of infection. Used only under specialist supervision with regular monitoring. This is given only by specialists in a hospital or clinic setting and is never for self-use.
Precautions & side effects
Ravulizumab is a powerful medicine that suppresses the immune system, and therefore, several important precautions must be taken. It is used only under specialist supervision with regular monitoring.
- Meningococcal Vaccination: Before starting treatment with Ravulizumab, it is mandatory to receive a meningococcal vaccination. This is because Ravulizumab can increase your risk of developing serious meningococcal infections, which can be life-threatening. Your doctor will discuss the vaccination schedule with you.
- Immune System Suppression and Infection Risk: As this medicine suppresses the immune system, it raises your risk of various infections. You must inform your doctor immediately if you develop any signs of infection, such as fever, chills, sore throat, cough, or unusual tiredness.
- Screening for Tuberculosis and Hepatitis: Before you begin treatment with Ravulizumab, your doctor will usually require screening tests for tuberculosis (TB) and hepatitis (especially Hepatitis B and C). This is to ensure that these infections are not active or to take necessary precautions if they are present, as the medicine could potentially worsen them.
- Specialist Supervision: This medicine is given only by specialists in a hospital or clinic setting. It requires careful monitoring throughout the treatment period.
- Not for Self-Use: Ravulizumab is never for self-use. It must always be administered by trained healthcare professionals.
- Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to discuss this with your doctor before starting Ravulizumab. They will weigh the potential benefits against the risks.
- Other Medications: Always inform your doctor about all other medicines you are taking, including over-the-counter drugs, herbal supplements, and vitamins, to avoid potential interactions.
Your doctor will provide you with a detailed understanding of all precautions and what to look out for during your treatment.
Understanding Neuro-Ophthalmological Conditions
Neuro-ophthalmology is a specialized field that focuses on eye problems related to the nervous system. Our eyes are incredibly complex organs, and their function is closely linked to our brain and nerves. Conditions like Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myasthenia Gravis (MG) are examples of such neuro-ophthalmological disorders. In NMOSD, the body’s immune system mistakenly attacks the optic nerves and spinal cord, leading to inflammation and damage that can cause vision loss, pain, and other neurological symptoms. Myasthenia Gravis, on the other hand, involves muscle weakness that can affect eye movements, causing drooping eyelids or double vision, among other issues. These conditions can be challenging, but with proper diagnosis and treatment, managing symptoms and improving quality of life is possible. Pristine Eye Hospitals is dedicated to providing comprehensive care for patients with these complex conditions, ensuring you receive the best possible treatment and support.
General Advice for Patients Receiving IV Infusions
Receiving an intravenous (IV) infusion, like Ravulizumab, is a common medical procedure, but it’s natural to have questions. Here’s what you can generally expect and how to prepare: Before your appointment, ensure you have eaten a light meal and are well-hydrated unless your doctor advises otherwise. Wear comfortable clothing that allows easy access to your arm for the IV line. When you arrive at the hospital or clinic, a nurse will prepare you for the infusion. This involves checking your vital signs and inserting a small needle, usually into a vein in your arm or hand, to start the drip. The medicine will then slowly flow into your bloodstream over a period of time. During the infusion, you will be in a comfortable chair or bed, and medical staff will monitor you closely for any reactions. It’s a good idea to bring a book, music, or a tablet to help pass the time. If you feel any discomfort, pain, or notice any unusual symptoms during the infusion, please inform the nurse or doctor immediately. After the infusion is complete, the needle will be removed, and a small bandage will be applied. You will receive instructions on what to do and what to watch out for after you go home. Always follow your doctor’s advice regarding follow-up appointments and any specific care instructions.
Importance of Hygiene, Storage, and When to Seek Help
Maintaining good personal hygiene is always important, but it becomes even more critical when you are on a medicine like Ravulizumab that suppresses your immune system. Wash your hands frequently with soap and water, especially before eating and after using the restroom. Try to avoid close contact with people who are sick. If you develop any signs of infection, such as fever, chills, persistent cough, sore throat, unusual fatigue, or any new or worsening symptoms, it is crucial to contact your doctor immediately. Do not wait, as infections can become serious quickly when your immune system is suppressed. Regarding the medicine itself, Ravulizumab is stored and administered by the hospital or clinic, so you do not need to worry about home storage. However, always keep all your other medications, including eye drops or ointments, stored safely away from children and pets, in a cool, dry place as instructed by your pharmacist. Never use expired medications. Finally, always remember that your healthcare team at Pristine Eye Hospitals is here to support you. If you have any concerns about your treatment, your condition, or your general well-being, do not hesitate to reach out to your doctor or nurse. Early communication can help address issues promptly and ensure the best possible outcomes for your health.
Frequently asked questions
What is Ravulizumab used for?
Ravulizumab is used to treat serious neuro-ophthalmological conditions such as Neuromyelitis Optica Spectrum Disorder (NMOSD) and refractory Myasthenia Gravis (MG).
How does Ravulizumab work?
Ravulizumab works by blocking a specific part of the immune system called the C5 complement protein, which helps reduce the harmful immune activity that causes inflammation and damage in conditions like NMOSD and refractory MG.
What are the common Indian brands for Ravulizumab?
In India, Ravulizumab is available under the brand name Ultomiris.
How is Ravulizumab administered?
Ravulizumab is given as an intravenous (IV) infusion directly into your vein, typically every 8 weeks, by healthcare professionals in a hospital or clinic setting. It is never for self-use.
Do I need a prescription for Ravulizumab?
Yes, Ravulizumab is a prescription-only medicine and is used only in a hospital or clinic setting under specialist supervision.
What are the key precautions I should be aware of with Ravulizumab?
Key precautions include requiring meningococcal vaccination before starting treatment, screening for tuberculosis and hepatitis, and understanding that it suppresses the immune system, increasing the risk of infection. It is only used under specialist supervision with regular monitoring.
References
- Ravulizumab-cwvz Injection: MedlinePlus Drug Information
- Ultomiris, INN-ravulizumab – European Medicines Agency (EMA)
- Clinical Review – Ravulizumab (Ultomiris) – NCBI – NIH
- Eye health information – American Academy of Ophthalmology
- Learn about eye health – National Eye Institute (NIH)
Medically reviewed by Dr. C Jagadesh Reddy, Chief Surgeon: Cornea, Cataract and Refractive Surgery — last reviewed 2026-07-28.
This page is for general education only and is not a substitute for professional medical advice, diagnosis or treatment. Never self-medicate or reuse an old prescription. Always consult a qualified ophthalmologist before starting, changing or stopping any eye medicine.